Search Results - "WAGNER, Alan C"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    A novel approach to oral apoA-I mimetic therapy[S] by Chattopadhyay, Arnab, Navab, Mohamad, Hough, Greg, Gao, Feng, Meriwether, David, Grijalva, Victor, Springstead, James R., Palgnachari, Mayakonda N., Namiri-Kalantari, Ryan, Su, Feng, Van Lenten, Brian J., Wagner, Alan C., Anantharamaiah, G.M., Farias-Eisner, Robin, Reddy, Srinivasa T., Fogelman, Alan M.

    Published in Journal of lipid research (01-04-2013)
    “…Transgenic tomato plants were constructed with an empty vector (EV) or a vector expressing an apoA-I mimetic peptide, 6F. EV or 6F tomatoes were harvested,…”
    Get full text
    Journal Article
  2. 2

    Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I by Van Lenten, Brian J., Wagner, Alan C., Jung, Chun-Ling, Ruchala, Piotr, Waring, Alan J., Lehrer, Robert I., Watson, Andrew D., Hama, Susan, Navab, Mohamad, Anantharamaiah, G.M., Fogelman, Alan M.

    Published in Journal of lipid research (01-11-2008)
    “…4F is an anti-inflammatory, apolipoprotein A-I (apoA-I)-mimetic peptide that is active in vivo at nanomolar concentrations in the presence of a large molar…”
    Get full text
    Journal Article
  3. 3

    Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis by Navab, Mohamad, Chattopadhyay, Arnab, Hough, Greg, Meriwether, David, Fogelman, Spencer I., Wagner, Alan C., Grijalva, Victor, Su, Feng, Anantharamaiah, G.M., Hwang, Lin H., Faull, Kym F., Reddy, Srinivasa T., Fogelman, Alan M.

    Published in Journal of lipid research (01-04-2015)
    “…We previously reported that i) a Western diet increased levels of unsaturated lysophosphatidic acid (LPA) in small intestine and plasma of LDL receptor null…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits by Van Lenten, Brian J., Wagner, Alan C., Navab, Mohamad, Anantharamaiah, G.M., Hama, Susan, Reddy, Srinivasa T., Fogelman, Alan M.

    Published in Journal of lipid research (01-11-2007)
    “…Rabbits on a 1% cholesterol diet received injections of vehicle with or without D-4F or L-4F. After 1 month, the percent of aorta with atherosclerotic lesions…”
    Get full text
    Journal Article
  6. 6

    High-density lipoprotein loses its anti-inflammatory properties during acute Influenza A infection by VAN LENTEN, Brian J, WAGNER, Alan C, NAYAK, Debi P, HAMA, Susan, NAVAB, Mohamad, FOGELMAN, Alan M

    Published in Circulation (New York, N.Y.) (08-05-2001)
    “…Viruses have been identified as one of a variety of potential agents that are implicated in atherogenesis. C57BL/6J mice were killed before or 2, 3, 5, 7, or 9…”
    Get full text
    Journal Article
  7. 7
  8. 8

    L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice by Imaizumi, Satoshi, Grijalva, Victor, Navab, Mohamad, Van Lenten, Brian J, Wagner, Alan C, Anantharamiah, G M, Fogelman, Alan M, Reddy, Srinivasa T

    Published in Drug metabolism letters (01-08-2010)
    “…To determine in vivo if L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL. Injecting L-4F into apoE null…”
    Get more information
    Journal Article
  9. 9

    High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism: Novel Hypotheses and Review of Literature by Navab, Mohamad, Reddy, Srinivasa T, Van Lenten, Brian J, Buga, Georgette M, Hough, Greg, Wagner, Alan C, Fogelman, Alan M

    “…Oxidized phospholipids are found in the vasculature of animal models of atherosclerosis, in human atherosclerotic lesions, and in other inflammatory diseases…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Apolipoprotein A-I mimetic peptides by Van Lenten, Brian J., Wagner, Alan C., Anantharamaiah, G. M., Navab, Mohamad, Reddy, Srinivasa T., Buga, Georgette M., Fogelman, Alan M.

    Published in Current atherosclerosis reports (2009)
    “…Recent publications reveal the mechanism of action of apolipoprotein A-I (apoA-I) mimetic peptides to be the remarkable binding affinity that oxidized lipids…”
    Get full text
    Journal Article
  12. 12

    D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes by Van Lenten, Brian J, Wagner, Alan C, Navab, Mohamad, Anantharamaiah, G M, Hui, Eric Ka-Wai, Nayak, Debi P, Fogelman, Alan M

    Published in Circulation (New York, N.Y.) (16-11-2004)
    “…Evidence suggests that apolipoprotein A-I (apoA-I) and HDL play important roles in modulating inflammation. We previously reported that an apoA-I mimetic…”
    Get full text
    Journal Article
  13. 13

    Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide by VAN LENTEN, Brian J, WAGNER, Alan C, ANANTHARAMAIAH, G. M, GARBER, David W, FISHBEIN, Michael C, ADHIKARY, Lopa, NAYAK, Debi P, HAMA, Susan, NAVAB, Mohamad, FOGELMAN, Alan M

    Published in Circulation (New York, N.Y.) (27-08-2002)
    “…We reported that HDL loses its antiinflammatory properties during acute influenza A infection in mice, and we hypothesized that these changes might be…”
    Get full text
    Journal Article
  14. 14

    The double jeopardy of HDL by Navab, Mohamad, Ananthramaiah, G M, Reddy, Srinivasa T, Van Lenten, Brian J, Ansell, Benjamin J, Hama, Susan, Hough, Greg, Bachini, Eugene, Grijalva, Victor R, Wagner, Alan C, Shaposhnik, Zory, Fogelman, Alan M

    Published in Annals of medicine (Helsinki) (01-01-2005)
    “…The ability of high-density lipoprotein (HDL) to promote cholesterol efflux is thought to be important in its protection against cardiovascular disease…”
    Get more information
    Journal Article
  15. 15

    Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis by Charles-Schoeman, Christina, Banquerigo, Mona Lisa, Hama, Susan, Navab, Mohamad, Park, Grace S, Van Lenten, Brian J, Wagner, Alan C, Fogelman, Alan M, Brahn, Ernest

    Published in Clinical immunology (Orlando, Fla.) (01-05-2008)
    “…Abstract To evaluate the therapeutic potential of an apolipoprotein A-1 (apoA-1) mimetic peptide, D-4F, in combination with pravastatin in collagen-induced…”
    Get full text
    Journal Article
  16. 16

    Oxidized Phospholipids Induce Changes in Hepatic Paraoxonase and ApoJ but Not Monocyte Chemoattractant Protein-1 via Interleukin-6 by Van Lenten, Brian J., Wagner, Alan C., Navab, Mohamad, Fogelman, Alan M.

    Published in The Journal of biological chemistry (19-01-2001)
    “…In this study, we tested if interleukin-6 (IL-6) plays a role in mediating the effects of oxidized phospholipids (OXPL). Treatment of HepG2 cells with oxidized…”
    Get full text
    Journal Article
  17. 17

    Abstract 9179: Free Oxidized Fatty Acids Contribute to Pro-Inflammatory HDL by Van Lenten, Brian J, Wagner, Alan C, Reddy, Srinivasa T, Navab, Mohamad, Fogelman, Alan M

    Published in Circulation (New York, N.Y.) (22-11-2011)
    “…Abstract only Background: Based on previous studies we thought it likely that the content of oxidized phospholipids would be elevated in pro-inflammatory HDL…”
    Get full text
    Journal Article